Researchers at Stanford have developed a strategy to improve the efficacy of antibiotics by conjugating the antibiotic to a guanidinium-rich molecular transporter (GR-MoTr).
Stanford researchers have repurposed two existing drugs and created a combined nanoparticle formulation that provides both intraocular pressure management and neuroprotection for glaucoma therapy.
Stanford researchers have identified a new therapeutic application for metformin in preventing corticosteroid-associated bone death, or osteonecrosis (ON).
Stanford scientists have developed an advanced optical technology that can separate and recombine thousands of extremely close light frequencies with unprecedented precision.
Stanford scientists have developed a novel cardiac Ex-vivo Preservation System (EVPS) capable of maintaining hearts of any size warm and beating upon transport, expanding heart transplant options for pediatric populations.
Researchers at Stanford University have discovered that donor-specific anti-HLA antibodies can be used to detect and treat graft-versus-host disease (GVHD) in transplant recipients after allogenic transplantation.
Researchers at Stanford University have identified EP300 modulators as effective treatments for reducing skin scarring, demonstrating significant regeneration of hair follicles, sweat glands, and connective tissue architecture.
Stanford inventors have developed an optimal strain sensing network for continuous monitoring of cardiac strains to monitor cardiac health and assess real-time response to therapies.
Stanford doctors have developed an innovative left ventricular decompression vent with multiple-channels design that significantly enhances blood removal during cardiac surgery.
Stanford researchers have developed a novel therapeutic approach for neurodegenerative diseases by targeting endoplasmic reticulum (ER) stress in neurons using CHOP inhibitors, with significant potential for development into first-in-class neuroprotective drugs for neurodegene
The distal lung functions in gas exchange essential for breathing and can be critically affected by infectious respiratory diseases, bacteria, and other pathogens which can lead to pneumonia and life-threatening respiratory failure.
Researchers in Prof. Crystal Mackall's laboratory at Stanford University are focused on translational research related to cancer immunotherapy, including basic T-cell function and tumor immunology.